STOCK TITAN

PAVmed (PAVM) holders re-elect directors, expand ESPP shares and ratify CBIZ

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

PAVmed Inc. reported results of its annual stockholder meeting. Stockholders representing approximately 59.6% of shares outstanding and entitled to vote participated in person or by proxy. Management’s nominees Ronald M. Sparks and Timothy Baxter were re-elected as Class A directors.

Stockholders approved amendments to the Employee Stock Purchase Plan, increasing the total shares available from 15,774 to 215,774 and raising the annual limit on automatic share increases from 5,556 to 500,000. They also ratified CBIZ CPAs P.C. as the independent registered certified public accounting firm for the year ending December 31, 2026.

Positive

  • None.

Negative

  • None.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 5.07 Submission of Matters to a Vote of Security Holders Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Meeting participation 59.6% of shares Shares outstanding and entitled to vote represented at the annual meeting
Votes for Sparks 3,810,460 shares Votes for election of Ronald M. Sparks as Class A director
Votes for Baxter 3,815,060 shares Votes for election of Timothy Baxter as Class A director
ESPP share pool 215,774 shares Total common stock available under ESPP after 200,000 share increase
ESPP evergreen limit 500,000 shares New annual limit for ESPP evergreen increases, up from 5,556 shares
ESPP proposal support 3,780,854 shares for Votes in favor of ESPP amendments
Auditor ratification support 4,306,623 shares for Votes to ratify CBIZ CPAs P.C. as 2026 auditor
Employee Stock Purchase Plan financial
"A proposal to approve amendments to the Company’s Employee Stock Purchase Plan (the “ESPP”)"
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
evergreen provision financial
"raise the annual limit for increases under the evergreen provision from 5,556 to 500,000 shares"
An evergreen provision is a clause in a financing or contract that automatically renews or replenishes the arrangement unless one party actively cancels it, like a subscription that keeps renewing each term. For investors it matters because it creates predictable, ongoing access to funding or ongoing contractual obligations — helping liquidity and planning — but can also hide long-term commitments or dilution risks if not reviewed.
broker non-votes financial
"For Against Abstain Broker Non-Votes 3,780,854 95,874 1,222 457,041"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
independent registered certified public accounting firm financial
"ratify the appointment of CBIZ CPAs P.C. as the Company’s independent registered certified public accounting firm"
Definitive Proxy Statement regulatory
"in the Definitive Proxy Statement on Schedule 14A, filed by the Company on April 30, 2026"
A Definitive Proxy Statement is a detailed document that a company sends to its shareholders before a big meeting, like voting on important decisions. It explains what's being voted on and gives important information so shareholders can make informed choices. It matters because it helps shareholders understand and participate in key company decisions.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
false 0001624326 0001624326 2026-06-24 2026-06-24 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): June 24, 2026

 

PAVMED INC.

 

(Exact Name of Registrant as Specified in Charter)

 

Delaware   001-37685   47-1214177
(State or Other Jurisdiction   (Commission   (IRS Employer
of Incorporation)   File Number)   Identification No.)

 

360 Madison Avenue, 25th Floor, New York, New York   10017
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (917) 813-1828

 

N/A

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12).
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)).
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading symbol(s)   Name of each exchange on which registered
Common Stock, Par Value $0.01 Per Share   PAVM   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 
 

 

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Directors; Compensatory Arrangements of Certain Officers.

 

The information disclosed under Item 5.07 is incorporated herein by reference.

 

Item 5.07. Submission of Matters to a Vote of Security Holders.

 

On June 24, 2026, PAVmed Inc. (the “Company”) held an annual meeting of stockholders (the “Annual Meeting”). Stockholders representing approximately 59.6% of the shares outstanding and entitled to vote were present in person or by proxy. At the Annual Meeting, the stockholders elected each of management’s nominees for director and approved the other matters considered. A description of the matters considered by the stockholders and a tally of the votes on each such matter are set forth below.

 

1. The election of two members of the Company’s board of directors (the “Board”) as Class A directors, to hold office until the third succeeding annual meeting and until their respective successors are duly elected and qualified. The Board is divided into three classes, Class A, Class B and Class C. As of the Annual Meeting, there were two directors in Class A, Ronald M. Sparks and Timothy Baxter, whose terms expired at the Annual Meeting, two directors in Class B, Sundeep Agrawal, M.D. and Debra J. White, whose terms expire at the 2027 annual meeting of stockholders, and two directors in Class C, Lishan Aklog, M.D. and Michael J. Glennon, whose terms expire at the 2028 annual meeting of stockholders. The board nominated Mr. Sparks and Mr. Baxter for re-election as Class A directors. Each of the board’s nominees for director was elected, as follows:

 

Name  For   Authority Withheld   Broker Non-Votes 
Ronald M. Sparks   3,810,460    67,490    457,041 
Timothy Baxter   3,815,060    62,890    457,041 

 

2. A proposal to approve amendments to the Company’s Employee Stock Purchase Plan (the “ESPP”) to (i) increase the total number of shares of the Company’s common stock available under the ESPP by an additional 200,000 shares, from 15,774 shares to 215,774 shares and (ii) raise the annual limit for increases under the evergreen provision from 5,556 to 500,000 shares. The amendments were approved, as follows:

 

For  Against   Abstain   Broker Non-Votes 
3,780,854   95,874    1,222    457,041 

 

A more complete description of the ESPP, as amended, is set forth beginning on page 8 under “The ESPP Proposal” in the Definitive Proxy Statement on Schedule 14A, filed by the Company on April 30, 2026 (the “Definitive Proxy Statement”), which description is incorporated herein by reference. The description of the amendments does not purport to be complete and is qualified in its entirety by reference to the full text of the ESPP, which is included as Annex A to the Definitive Proxy Statement and is incorporated herein by reference.

 

3. A proposal to ratify the appointment of CBIZ CPAs P.C. as the Company’s independent registered certified public accounting firm for the year ending December 31, 2026. The ratification of the appointment of CBIZ CPAs P.C. was approved, as follows:

 

For  Against   Abstain   Broker Non-Votes 
4,306,623   25,814    2,554     

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits:

 

Exhibit No.   Description
     
10.1   Employee Stock Purchase Plan, as amended and restated on June 24, 2026 (incorporated by reference to Annex A to the Definitive Proxy Statement).
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

1
 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: June 24, 2026 PAVMED INC.
     
  By: /s/ Dennis McGrath
    Dennis McGrath
    President and Chief Financial Officer

 

2

FAQ

What did PAVM stockholders decide at the latest annual meeting?

Stockholders re-elected two Class A directors and approved all proposals. They amended the Employee Stock Purchase Plan and ratified CBIZ CPAs P.C. as independent auditor for the year ending December 31, 2026, reflecting broad support for current governance and oversight.

How many PAVM shares are now available under the Employee Stock Purchase Plan?

Stockholders approved increasing ESPP share availability to 215,774 shares. This raised the pool from the prior 15,774 shares, expanding capacity for employee stock purchases as described in the company’s Definitive Proxy Statement on Schedule 14A dated April 30, 2026.

What change did PAVM make to the ESPP evergreen provision limits?

The annual limit for ESPP evergreen increases was raised to 500,000 shares. Previously, the limit was 5,556 shares. This change potentially allows larger future annual increases to the ESPP share pool, subject to the plan’s terms described in the Definitive Proxy Statement.

Who were the PAVM directors elected at the 2026 annual meeting?

Ronald M. Sparks and Timothy Baxter were re-elected as Class A directors. They will serve until the third succeeding annual meeting and until their successors are duly elected and qualified, continuing on a staggered board with separate Class A, Class B, and Class C terms.

Which auditing firm did PAVM stockholders ratify for 2026?

Stockholders ratified CBIZ CPAs P.C. as independent registered certified public accounting firm for 2026. The vote totals were 4,306,623 shares for, 25,814 against, and 2,554 abstentions, with no broker non-votes recorded on this ratification proposal.

What was PAVM’s stockholder participation level at the 2026 annual meeting?

Approximately 59.6% of shares outstanding and entitled to vote were represented. Shares were present either in person or by proxy, providing the quorum needed to conduct business and approve director elections, ESPP amendments, and the auditor ratification proposals.

Filing Exhibits & Attachments

3 documents